[go: up one dir, main page]

DK173590D0 - Rekombinante terapeutiske lipaser - Google Patents

Rekombinante terapeutiske lipaser

Info

Publication number
DK173590D0
DK173590D0 DK173590A DK173590A DK173590D0 DK 173590 D0 DK173590 D0 DK 173590D0 DK 173590 A DK173590 A DK 173590A DK 173590 A DK173590 A DK 173590A DK 173590 D0 DK173590 D0 DK 173590D0
Authority
DK
Denmark
Prior art keywords
lipases
recombinant therapeutic
lipase
prophylaxis
mammals
Prior art date
Application number
DK173590A
Other languages
Danish (da)
English (en)
Inventor
Birgitte Huge-Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK137990A external-priority patent/DK137990D0/da
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK173590A priority Critical patent/DK173590D0/da
Publication of DK173590D0 publication Critical patent/DK173590D0/da
Priority to EP91910966A priority patent/EP0600868B1/en
Priority to JP03510710A priority patent/JP3072853B2/ja
Priority to AT91910966T priority patent/ATE178492T1/de
Priority to PCT/DK1991/000149 priority patent/WO1991018623A1/en
Priority to AU80964/91A priority patent/AU645583B2/en
Priority to CA002084184A priority patent/CA2084184A1/en
Priority to DE69131106T priority patent/DE69131106T2/de
Priority to FI925530A priority patent/FI925530L/fi
Priority to US08/318,036 priority patent/US5614189A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK173590A 1990-06-06 1990-07-19 Rekombinante terapeutiske lipaser DK173590D0 (da)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DK173590A DK173590D0 (da) 1990-06-06 1990-07-19 Rekombinante terapeutiske lipaser
DE69131106T DE69131106T2 (de) 1990-06-06 1991-06-04 Gentechnologisch hergestellte lipasen für die therapeutische behandlung
CA002084184A CA2084184A1 (en) 1990-06-06 1991-06-04 Recombinantly produced lipases for therapeutical treatment
AT91910966T ATE178492T1 (de) 1990-06-06 1991-06-04 Gentechnologisch hergestellte lipasen für die therapeutische behandlung
JP03510710A JP3072853B2 (ja) 1990-06-06 1991-06-04 治療用に、組換方法で生産されたリパーゼ
EP91910966A EP0600868B1 (en) 1990-06-06 1991-06-04 Recombinantly produced lipases for therapeutical treatment
PCT/DK1991/000149 WO1991018623A1 (en) 1990-06-06 1991-06-04 Recombinantly produced lipases for therapeutical treatment
AU80964/91A AU645583B2 (en) 1990-06-06 1991-06-04 Recombinantly produced lipases for therapeutical treatment
FI925530A FI925530L (fi) 1990-06-06 1992-12-04 Rekombinantiskt framstaellda lipaser foer terapeutiskt bruk
US08/318,036 US5614189A (en) 1990-06-06 1994-10-04 Recombinantly produced lipases for therapeutical treatment

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK137990A DK137990D0 (da) 1990-06-06 1990-06-06 Rekombinante terapeutiske lipaser
DK173590A DK173590D0 (da) 1990-06-06 1990-07-19 Rekombinante terapeutiske lipaser

Publications (1)

Publication Number Publication Date
DK173590D0 true DK173590D0 (da) 1990-07-19

Family

ID=26065679

Family Applications (1)

Application Number Title Priority Date Filing Date
DK173590A DK173590D0 (da) 1990-06-06 1990-07-19 Rekombinante terapeutiske lipaser

Country Status (10)

Country Link
US (1) US5614189A (ja)
EP (1) EP0600868B1 (ja)
JP (1) JP3072853B2 (ja)
AT (1) ATE178492T1 (ja)
AU (1) AU645583B2 (ja)
CA (1) CA2084184A1 (ja)
DE (1) DE69131106T2 (ja)
DK (1) DK173590D0 (ja)
FI (1) FI925530L (ja)
WO (1) WO1991018623A1 (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140475A (en) * 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
US6541606B2 (en) 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
EP1729797B1 (en) 2004-03-22 2008-09-10 Solvay Pharmaceuticals GmbH Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
MXPA06013239A (es) * 2004-05-24 2007-02-28 Novozymes As Enzimas para uso farmaceutico.
HUE031245T2 (en) 2004-10-14 2017-06-28 Lilly Co Eli Preparations containing lipase, protease and amylase for the treatment of pancreatic insufficiency
EP1896058A2 (en) * 2005-06-24 2008-03-12 Novozymes A/S Proteases for pharmaceutical use
NZ563693A (en) * 2005-06-24 2010-08-27 Novozymes As Lipases derived from Thermocyces lanuginosus optionally in combination with a protease and/or amylase for pharmaceutical use
EP1896057A2 (en) 2005-06-24 2008-03-12 Novozymes A/S Amylases for pharmaceutical use
UA93384C2 (ru) 2005-07-29 2011-02-10 Солвей Фармасьютикалс Гмбх Способ получения стерилизированного порошкообразного панкреатина
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
US8071089B2 (en) 2005-11-01 2011-12-06 Bio-Cat, Inc. Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency
US20070104805A1 (en) * 2005-11-01 2007-05-10 Udell Ronald G Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
MX2009006597A (es) 2006-12-21 2009-07-02 Novozymes As Variantes de lipasa para uso farmaceutico.
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
JP2011505160A (ja) * 2007-12-04 2011-02-24 ノボザイムス アクティーゼルスカブ 医薬用途のためのプロテアーゼ変異体
EP2237771A1 (en) * 2008-01-03 2010-10-13 Abbott Products GmbH Pharmaceutical compositions comprising granules of purified microbial lipase and methods of preventing or treating digestive disorders
JP5970189B2 (ja) * 2009-01-29 2016-08-17 ノルドマルク・アルツナイミッテル・ゲゼルシヤフト・ミト・ベシュレンクテル・ハフツング・ウント・コンパニー・コマンデイトゲゼルシヤフト 医薬調製物
WO2011000924A1 (en) 2009-07-03 2011-01-06 Abbott Products Gmbh Spray-dried amylase, pharmaceutical preparations comprising the same and use
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
CA2919114A1 (en) * 2013-07-22 2015-02-12 Aptalis Pharma Ltd. High potency pancreatin pharmaceutical compositions
JP2014193909A (ja) * 2014-06-04 2014-10-09 Nordmark Arzneimittel Gmbh & Co Kg 医薬調製物
GB201501081D0 (en) * 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion
US20180028454A1 (en) 2015-02-04 2018-02-01 Abbvie Inc. Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency
DE102015114857A1 (de) * 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Getränk, enthaltend eine pharmazeutische Zusammensetzung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8421210D0 (en) * 1984-08-21 1984-09-26 Celltech Ltd Polypeptide and polypeptide composition
US4659667A (en) * 1985-02-26 1987-04-21 Miles Laboratories, Inc. Process to recover crystalline enzymes and crystalline enzymes produced thereby
US5108457A (en) * 1986-11-19 1992-04-28 The Clorox Company Enzymatic peracid bleaching system with modified enzyme
EP0305216B1 (en) * 1987-08-28 1995-08-02 Novo Nordisk A/S Recombinant Humicola lipase and process for the production of recombinant humicola lipases
ATE94206T1 (de) * 1989-12-21 1993-09-15 Novo Nordisk As Enzymhaltige zubereitung und eine solche zubereitung enthaltendes detergens.

Also Published As

Publication number Publication date
EP0600868A1 (en) 1994-06-15
AU645583B2 (en) 1994-01-20
AU8096491A (en) 1991-12-31
US5614189A (en) 1997-03-25
FI925530A0 (fi) 1992-12-04
WO1991018623A1 (en) 1991-12-12
DE69131106T2 (de) 1999-11-18
JP3072853B2 (ja) 2000-08-07
DE69131106D1 (de) 1999-05-12
CA2084184A1 (en) 1991-12-07
JPH06501147A (ja) 1994-02-10
FI925530L (fi) 1992-12-04
ATE178492T1 (de) 1999-04-15
EP0600868B1 (en) 1999-04-07

Similar Documents

Publication Publication Date Title
DK173590D0 (da) Rekombinante terapeutiske lipaser
ATE237633T1 (de) Analogen des keratinozytenwachstumfaktors
MY101842A (en) Treatment of oral diseases.
ES2007625A6 (es) Un procedimiento para la produccion de una proteina para huesos y cartilagos.
DK0611522T3 (da) Synergistiske mikrobicide sammensætninger
TW262461B (ja)
DE69435096D1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
AU563748B2 (en) Quinolone carboxylic acids
PT764167E (pt) Inibidor biciclico de lactama do enzima de conversao da beta-interleucina-1
JPS5799576A (en) 3-(p-alkylsulfonylphenyl)oxazolidinone derivatives
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
IL64885A (en) 3,20-dioxo-1,4-pregnadiene-17alpha-ol-17-aromatic heterocyclic esters,their preparation and pharmaceutical compositions containing them
HK1005241A1 (en) Cell adhesion inhibitors
AP9100310A0 (en) Tnf inhibitors
RU94020410A (ru) Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений
CA2267932A1 (en) Compositions for postgastrectomic mineral supply
DE69432573D1 (de) Inhibitoren des Endothelin konvertierenden Enzyms
NO171634C (no) Analogifremgangsmaate for fremstilling av alfa-aryl-4-(4,5-dihydro-3,5-diokso-1,2,4-triazin-2(3h)-yl)-benzenacetonitriler
FI970203A0 (fi) Pyridyylitioyhdisteet helikobakteerien torjumiseksi
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
NO177055C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-oksetanoner
EP0618812A4 (en) USE OF PROTEASE NEXIN-I AS ANTI-INFLAMMATORY.
IE890612L (en) Inhibitors of lysyl oxidase
BR9500886A (pt) Composições com efeito regulador de crescimento e método para o tratamento de culturas
EP0297816A3 (en) Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
B1 Patent granted (law 1993)
PUP Patent expired